Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Initiates 'Substantive' Relationship With China's BGI
Seeking Alpha
Thursday, September 16, 2010 - 12:14pm
tags:
China, Merck, BGI
Forest Unit Pleads Guilty to Marketing Thyroid Drug, Will Pay $313 Million
Bloomberg
Thursday, September 16, 2010 - 6:30am
tags:
Levothroid, Forest Labs, lawsuits, settlements, Celexa, Lexapro
4 Solid Pharmaceutical Dividend Plays
Seeking Alpha
Thursday, September 16, 2010 - 6:27am
tags:
dividends, Eli Lilly, Pfizer, GSK, Bristol-Myers Squibb
Biogen Idec: A High Value, High Profit Stock
Seeking Alpha
Wednesday, September 15, 2010 - 9:48pm
tags:
Biogen Idec
FDA panel split on withdrawing diet pill Meridia
Yahoo/AP
Wednesday, September 15, 2010 - 9:47pm
tags:
FDA, advisory panels, Abbott Laboratories, Meridia
The Next Big Rare Disease Drug?
Forbes
Wednesday, September 15, 2010 - 9:46pm
tags:
Incyte, Novartis, Janus kinase, AstraZeneca, Eli Lilly, Sanofi
Cell Therapeutics Goes for Broke
Motley Fool
Wednesday, September 15, 2010 - 3:17pm
tags:
Cell Therapeutics, FDA, pixantrone
Avandia: a PR mess for Glaxo, but not a financial one
CNN/Fortune
Wednesday, September 15, 2010 - 3:15pm
tags:
diabetes, Avandia, GSK
Some Docs Believe They Deserve Dinners And Gifts
Pharmalot
Wednesday, September 15, 2010 - 12:49pm
tags:
physician gifts
Sanofi CEO sees reasonable chance of Genzyme deal
Yahoo/Reuters
Wednesday, September 15, 2010 - 12:47pm
tags:
Genzyme, Sanofi, Pharma CEOs, Chris Viehbacher, M&A
Rodman Rambles: Promising Biotechs
TheStreet.com
Wednesday, September 15, 2010 - 10:55am
tags:
AVI BioPharma, Athersys, BioDelivery Sciences, Dendreon, Neoprobe, RXi Pharmaceuticals, Polymedics, Alexion, Biomarin
Genzyme confirms 1,000 job cuts over 15 months
Yahoo/Reuters
Wednesday, September 15, 2010 - 10:52am
tags:
layoffs, Genzyme, M&A, Sanofi
Arena: This One-Trick Pony Is Safe to Short
Seeking Alpha
Wednesday, September 15, 2010 - 10:47am
tags:
Arena Pharmaceuticals, obesity, Abbott Laboratories, Meridia
Biodel's Linjeta Should Overcome the Usual FDA Approval Hurdles
Seeking Alpha
Wednesday, September 15, 2010 - 10:46am
tags:
FDA, Biodel, Linjeta, diabetes, MannKind, inhaled insulin, Afrezza, insulin injectables
Novo Nordisk to Double China R&D Headcount
Seeking Alpha
Wednesday, September 15, 2010 - 9:23am
tags:
R&D, Novo Nordisk, China
Analyst lowers rating on GlaxoSmithKline due to greater risk of Avandia withdrawals
Yahoo/AP
Wednesday, September 15, 2010 - 9:21am
tags:
Avandia, analysts, GSK
Live Blog: Odds Stacked Against FDA's Panel Approving Abbott's Meridia
Minyanville
Wednesday, September 15, 2010 - 8:08am
tags:
FDA, Meridia, Abbott Laboratories, obesity
Savient Investors Expect a Sale
TheStreet.com
Wednesday, September 15, 2010 - 8:06am
tags:
Savient, M&A, gout, FDA, Krystexxa, JNJ, Pfizer, Amgen, Novartis, Bristol-Myers Squibb
FDA extends time for AstraZeneca's ticagrelor NDA
Marketwatch
Wednesday, September 15, 2010 - 8:04am
tags:
AstraZeneca, FDA, Ticagrelor, Brilinta, anti-clotting
Sanofi Chief Says Genzyme Shareholders Will Sell for `Reasonable Price'
Bloomberg
Wednesday, September 15, 2010 - 7:39am
tags:
Genzyme, shareholders, Sanofi, Chris Viehbacher, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.